| Filed On | Filing |
|---|---|
| 14 Aug 2026 | FORM 10-Q |
| 12 Jun 2026 | ARS |
| 12 Jun 2026 | DEF 14C |
| 15 May 2026 | FORM 10-Q |
| 31 Mar 2026 | FORM 10-K |
| 16 Jan 2026 | 8-K: Changes in Registrant's Certifying Accountant |
| 14 Nov 2025 | FORM 10-Q |
| 13 Aug 2025 | FORM 10-Q |
| 25 Jul 2025 |
Form 4: Wang Jun, Director
Received 42,000,000 shares as a grant or award ($2.1M) |
| 25 Jul 2025 |
Form 4: Wang Yang, Director
Received 8,600,000 shares as a grant or award ($430K) |
| 25 Jul 2025 | SCHEDULE 13D/A |
| 25 Jul 2025 | SCHEDULE 13D/A |
| 25 Jul 2025 | 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 03 Jun 2025 | SCHEDULE 13G |
| 03 Jun 2025 |
Form 4: Boao Biotech Ltd, 10% owner and 1 other
Sold 5,040,140 shares ($1.51M) |
| 02 Jun 2025 |
Form 4: Wang Yang, Director
Sold 2,000,000 shares ($240K) |
| 14 May 2025 | FORM 10-Q |
| 05 May 2025 |
Form 3: Hu Nanping, Director
Holds 0 shares of Class A Common Stock, par value $0.001 per share |
| 25 Apr 2025 | null |
| 14 Apr 2025 | DEF 14C |
Loading...
